Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.
Leukemia. 2023 Jun;37(6):1379-1383. doi: 10.1038/s41375-023-01897-x. Epub 2023 Apr 21.
Leukemia. 2023.
PMID: 37085610
Free PMC article.
No abstract available.
Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy.
Zhang W, Yu G, Zhang H, Basyal M, Ly C, Yuan B, Ruvolo V, Piya S, Bhattacharya S, Zhang Q, Borthakur G, Battula V, Konopleva M, Rice WG, Andreeff M.
Zhang W, et al. Among authors: ly c.
Haematologica. 2023 Jun 1;108(6):1500-1514. doi: 10.3324/haematol.2022.280884.
Haematologica. 2023.
PMID: 36226489
Free PMC article.
Item in Clipboard
High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cells.
Zeng Z, Ly C, Daver N, Cortes J, Kantarjian HM, Andreeff M, Konopleva M.
Zeng Z, et al. Among authors: ly c.
Ann Hematol. 2021 Jun;100(6):1485-1496. doi: 10.1007/s00277-021-04493-0. Epub 2021 Mar 31.
Ann Hematol. 2021.
PMID: 33787984
Item in Clipboard
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial.
Zhang W, Ly C, Ishizawa J, Mu H, Ruvolo V, Shacham S, Daver N, Andreeff M.
Zhang W, et al. Among authors: ly c.
Haematologica. 2018 Oct;103(10):1642-1653. doi: 10.3324/haematol.2017.185082. Epub 2018 May 17.
Haematologica. 2018.
PMID: 29773601
Free PMC article.
Clinical Trial.
Item in Clipboard
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases.
Yu G, Zhang W, Zhang H, Ly C, Basyal M, Rice WG, Andreeff M.
Yu G, et al. Among authors: ly c.
Res Sq [Preprint]. 2023 Feb 22:rs.3.rs-2570204. doi: 10.21203/rs.3.rs-2570204/v1.
Res Sq. 2023.
PMID: 36865133
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite